CNIO researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment (IMAGE)

Centro Nacional de Investigaciones Oncológicas (CNIO)

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.